Skip to content
VuFind
  • Book Bag: 0 items (Full)
  • Institutional Login
    • English
    • Deutsch
Advanced
  • Start
  • Cite this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
    • Export to RDF
    • Export to BibTeX
    • Export to RIS
  • Save to List
  • Permanent link
Cover Image

Saved in:
Bibliographic Details
Main Author: Middeke, Andreas (Author)
Online Access: Get full text
  • Description
  • Staff View
Description
Description not available.

Similar Items


  • by: Middeke, Martin
  • Insufficient reply by Hermida et al. to the critical comments to the MAPEC and HYGIA studies
    by: Lemmer, Björn, et al.
    Published: (2020)
  • Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    by: Middeke, Jan Moritz, et al.
    Published: (2016)
  • Long-term follow-up and impact of comorbidity before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory acute myeloid leukemia: lessons learned from the prospective BRIDGE Trial
    by: Middeke, Jan Moritz, et al.
    Published: (2017)
  • Outcome of high-risk acute myeloid leukemia after allogeneic hematopoietic cell transplantation: negative impact of abnl(17p) and −5/5q−
    by: Middeke, Jan Moritz, et al.
    Published: (2012)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically

Need Help?

  • Search Tips
  • Cookie Settings